Athira Pharma, Inc.

NasdaqGS:ATHA Stock Report

Market Cap: US$21.0m

Athira Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ATHA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Sep 24SellUS$2,848Mark LittonIndividual5,032US$0.57
05 Sep 24SellUS$1,429Mark WorthingtonIndividual2,525US$0.57
05 Sep 24SellUS$1,429Kevin ChurchIndividual2,525US$0.57
05 Sep 24SellUS$1,429Rachel LeningtonIndividual2,525US$0.57
05 Sep 24SellUS$720Andrew GengosIndividual1,272US$0.57
24 Jun 24BuyUS$100,051Kelly RomanoIndividual42,400US$2.42
05 Jan 24SellUS$7,019Kevin ChurchIndividual2,412US$2.91
05 Jan 24SellUS$3,515Andrew GengosIndividual1,208US$2.91
05 Jan 24SellUS$7,019Rachel LeningtonIndividual2,412US$2.91
05 Jan 24SellUS$14,026Mark LittonIndividual4,820US$2.91
05 Jan 24SellUS$7,019Mark WorthingtonIndividual2,412US$2.91
29 Dec 23BuyUS$1,462,895Perceptive Advisors LLCCompany605,686US$2.44

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATHA?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds2,233,1675.78%
Individual Insiders3,101,2728.02%
VC/PE Firms5,402,96414%
Institutions10,922,65128.2%
General Public17,009,01944%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 52.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Perceptive Advisors LLC
5,402,964US$2.9m0%0.07%
5.78%
BML Capital Management, LLC
2,233,167US$1.2m148%0.7%
5.13%
Richard Kayne
1,983,468US$1.1m0%no data
4.17%
The Vanguard Group, Inc.
1,613,063US$874.3k-1.31%no data
3.86%
Simplify Asset Management Inc.
1,492,792US$809.1k0%0.06%
3.86%
Propel Bio Management, LLC
1,492,792US$809.1k0%0.84%
1.55%
Tang Capital Management, LLC
600,000US$325.2k-43%0.03%
1.38%
BlackRock, Inc.
535,543US$290.3k-20.8%no data
1.27%
Pathstone Family Office, LLC
492,126US$266.7k-0.02%no data
1.23%
Acadian Asset Management LLC
476,502US$258.3k49.8%no data
1.17%
Renaissance Technologies LLC
452,787US$245.4k66.8%no data
1.11%
Bank of America Corporation, Asset Management Arm
427,928US$231.9k87.9%no data
1.03%
GSA Capital Partners LLP
397,111US$215.2k910%0.02%
0.87%
Two Sigma Advisers, LP
337,600US$183.0k-6.46%no data
0.87%
Bristlecone Advisors LLC
337,506US$182.9k296%0.02%
0.83%
Dimensional Fund Advisors LP
321,447US$174.2k-41.6%no data
0.83%
Geode Capital Management, LLC
320,844US$173.9k4.45%no data
0.67%
Two Sigma Investments, LP
258,473US$140.1k-14.5%no data
0.65%
Braden Leonard
251,278US$136.2k0%no data
0.46%
Mark Litton
179,054US$97.0k9.12%no data
0.38%
Laird Norton Tyee Trust Company
147,309US$79.8k0%0.01%
0.37%
John Fluke
144,884US$78.5k0%no data
0.34%
Securities America Advisors, Inc.
132,439US$71.8k0%no data
0.28%
State Street Global Advisors, Inc.
107,781US$58.4k0%no data
0.25%
Andrew Gengos
97,532US$52.9k16.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:36
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Athira Pharma, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Esther Lannie HongBerenberg
Thomas ShraderBTIG
Corinne JohnsonGoldman Sachs